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Abstract 
Objectives: Ulcerative colitis (UC) is associated with an increased risk of colorectal 
cancer (CRC). Few studies have looked at long term outcomes of endoscopically visible 
adenomatous lesions removed by endoscopic resection in these patients. We aimed to 
assess the risk of developing CRC in UC patients with adenomatous lesions that 
develop within the segment of colitis compared to the remainder of an ulcerative colitis 
cohort. 
 Methods: We identified patients with a confirmed histological diagnosis of UC from 
1991-2004 and noted outcomes till June 2011. The Kaplan–Meier method was used to 
estimate cumulative probability of subsequent CRC. Factors associated with risk of 
CRC were assessed in a Cox proportional hazards model.  
Results: 29 of 301 patients with UC had adenomatous lesions noted within the segment 
of colitis.  The crude incidence rate of developing colon cancer in patients with UC was 
2.45 (95% CI 1.06-4.83) per 1000 PYD and in those with UC and polypoid adenomas 
within the extent of inflammation was 11.07 (95% CI 3.59-25.83) per 1000 PYD. 
Adjusted Hazards ratio of developing CRC on follow up in UC patients with polypoid 
dysplastic adenomatous lesions within the extent of inflammation was 4.0 (95% CI 1.3-
12.4). 
Conclusions:  The risk of developing CRC is significantly higher in UC patients with 
polypoid adenomatous lesions, within the extent of inflammation, despite endoscopic 
resection. Patients and physicians should take the increased risk into consideration 
during follow up of these patients.  
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Introduction 
Patients with long standing, extensive ulcerative colitis (UC) have an increased risk for 
developing colorectal carcinoma[1]. Since the first description by Blackstone et. al. the 
finding of a raised dysplastic lesion was considered an ominous finding[2].  Of 112 
patients with UC in this study, 12 raised lesions with dysplasia were found and 7 (58%) 
of them had invasive cancer in the colectomy specimen. The term dysplasia associated 
lesion/mass (DALM) was coined to describe these lesions. Subsequently Bernstein et. 
al. in a systematic review of 10 prospective studies found that 17(43%) of 40 cases with 
DALM’s had associated colon cancer[3]. 
The treatment of patients with UC and DALM’s has remained controversial. Blackstone 
et.al. suggested that dysplasia associated with a DALM, especially a polypoid mass was 
an indication for colectomy in view of the increased likelihood of cancer[2]. Several 
subsequent studies seem to support this argument [4]. The criticism leveled at these 
studies was that the lesions detected were fairly advanced, and despite endoscopic 
biopsies not revealing a cancer, subsequent surgery and histological examination of the 
specimens revealed the underlying cancer. More recently a distinction has been made 
between sporadic adenomas which have been described as discrete well defined, 
sessile or pedunculated polyps resembling adenomas in patients without inflammatory 
bowel disease and other (non-adenoma like) DALM’s which are broad based sessile, 
irregular, ulcerating or stricturing lesions[5]. Other studies have classed only those 
polyps outside the extent of histological inflammation as sporadic adenomas further 
adding to the confusion in terminology of these lesions [6]. The recent SCENIC 
guidelines suggests using the standard Paris classification for colorectal lesions along 
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with additional descriptors of whether the lesions was within the colitic segment , 
circumscribed endoscopic resectability and associated ulceration[7]. A systematic 
review which included 10 studies, with 376 IBD patients with resected polypoid 
dysplasia followed up for a mean of 54 months, reported an pooled incidence for 
dysplasia and CRC of 65 and 5.3 cases per 1000 patient years respectively[8].  
On the basis of these studies it has been suggested that patients with endoscopically 
resectable raised dysplastic lesions associated with UC should not have colectomy.  
The recommendation of the SCENIC panel based on 9 studies reviewed (all 
retrospective and single arm) on the endoscopic management of polypoid dysplastic 
lesions during the video-endoscope era was: endoscopic resection with continued 
surveillance [7].  One of the major criticisms of these studies was that they were mainly 
single arm (no comparator) and did not take into account other risk factors for cancer. 
Risk of cancer in patients with UC is a dependent on  disease duration[1] and also on 
age[9], sex[10] and extent of disease[1,9]. Risks of cancer in patients with UC are 
therefore best expressed on the basis of duration of disease and adjusted for risk 
factors.  A Dutch pathology database (PALGA) study showed that the adjusted risk of 
developing advanced neoplasia on follow up for patients with IBD and adenomas 
compared to IBD patients without adenomas was 2.8 fold higher (95% CI 1.0-8.2) 
underscoring the need for intensive surveillance following endoscopic resection [11].   
Aims of the study 
The aim of this study was to compare the risk of subsequently developing colorectal 
cancer in patients with UC and endoscopically resectable polypoid dysplastic lesions 
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within the extent of histological inflammation compared to the remainder of the UC 
cohort.   
Methods 
Subjects 
All adult patients with a histological diagnosis of ulcerative colitis made between 1991-
2004, were identified from the histopathology database at St George’s Hospital, London 
a larger University teaching hospital. Patients were included in the study only if they had 
undergone colonoscopy with segmental biopsies in this institution. Standard protocol 
was performed taking biopsies from all segments of the colon. Patients who were not 
under follow up primarily at St George’s Hospital and referred with a diagnosis of colon 
cancer were excluded from the study. All data on endoscopy and histology was 
obtained from the electronic patients records of St George’s Hospital. If data was 
incomplete or unclear in the electronic records, patient charts were traced through 
medical records and scrutinized. For this study, duration of follow up was defined as the 
time from which the histological diagnosis of UC was first confirmed to the time when 
the last colonoscopy with segmental biopsies was performed in this hospital, or to the 
time when total or subtotal colectomy was done.  Follow up data noted on the electronic 
patient records till June 2011 was recorded (at least 7 years after the last inclusion 
colonoscopy). Histopathology and endoscopy reports were reviewed to detect whether 
patients developed further adenamtous lesions with low grade dysplasia, high grade 
dysplasia, or CRC during follow-up.   
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Since this was a retrospective study we did not attempt to distinguish between ALM’s 
and DALM’s.  Patients with raised endoscopically resectable dysplastic polypoid lesions 
seen within the extent of colonic inflammation with no evidence of flat dysplasia 
adjacent or remote to the polypoid lesion were included in the UC with adenomatous 
polyp arm.  All other patients with UC were placed in the comparison cohort. The 
endoscopy report was used to determine the location and size of the polyp and whether 
the polyp was resected endoscopically.  Standard snare resection techniques were 
used for stalked polyps and endoscopic mucosal resection after submucosal injection of 
saline or a hypertonic solution was used for sessile and non-polypoid lesions based on 
the endoscopists choice. Completeness of resection was based on endoscopist’s 
impression where available.   
Dysplasia was classified as either low-grade or highgrade, according to standard criteria 
and definitions based on Ridell et,al[12]. Histopathology reports were based on routine 
reporting by a GI histopathologists and a discussion of the pathology at the weekly 
multi-discliplinary team meeting where the pathology would be reviewed bya second GI 
hiatopatholgist. 
Statistical analysis 
Statistical analysis was done using SPSS version 21 (IBM corporation, USA) statistical 
package. All baseline values were recorded as mean  standard deviation (SD) or 
percentages.  Crude incidence rates (number of cases during the period of observation 
divided by the total person-time of observation)  for each group were calculated and 
expressed as number of cases per 1000 persons years of disease duration (PYD).  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
The Kaplan–Meier method was used to estimate cumulative probability (1 minus 
survival free) of subsequent CRC. Comparisons between groups were made using 
Breslow log-rank tests. The cox proportional hazards regression model was used to 
assess the associations of clinical variables on development of CRC. The following 
variables were assessed in these models: 1) presence of a endosocpically resectable 
polyp versus none detected; 2) disease extent (extensive versus other); 3) age at 
diagnosis and 4) gender (male or female). Results are reported as hazard ratios (HR) 
with 95% confidence intervals (95% CI). 
Results 
Of the 751 patients with a histological diagnosis of UC made between 1991-2004, 397 
patients had at least one colonoscopy with serial mucosal biopsies during this period. 
The remainder did not fulfill the inclusion criteria either because they had only a rigid or 
flexible sigmoidoscopy or had an incomplete colonoscopy  either because they did not 
tolerate the procedure or had poor bowel preparation. A further 96 did not have any 
further follow up at St George’s hospital till June 2011 and were excluded. Of the 301 
patients included 29 had endoscopically detected polypoid dysplastic lesions within the 
extent of colonic inflammation at some point. A further 5 patients had adenomas outside 
the extent of UC and were included in the comparison cohort of all other UC patients. 
Table 1 outlines the patient characteristics of these two groups and Figure 1 provides a 
flow chart showing the outcomes at end of follow up. Of the 29 patients with polypoid 
adenomatous lesions within the extent of colitis, 27 had their lesions endoscopically 
resected.  Table 2 outlines the salient characteristics of the polyps detected in this 
group.  One patient had a   sessile broad based polyp in the rectum with low grade 
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dysplasia on endoscopic biopsies and refused any endoscopic or surgical procedures 
and on follow up colonoscopy 27 months later had no progression of the lesion on 
repeat endoscopic biopsies.  Another patient with a sessile polypoid lesion in the 
descending colon with low grade dysplasia on endoscopic biopsies opted to have a 
colectomy, the specimen revealed no evidence of any invasive cancer or high grade 
dysplasia. Five patients developed invasive adenocarcinoma in the same segment 
between 14-48 months after the initial endoscopic resection.  Ten patients had recurrent 
polypoid dysplastic lesions noted in a median follow up of 49 months (range 12-108 
months) after the initial endoscopic resection, which were also endoscopically treated.  
Five of these 29 patients had high grade dysplasia on their initial endoscopic resection 
specimen of which 2 subsequently developed carcinoma on follow up.   
The comparison cohort consisted of 272 patients with UC with no polypoid dysplastic 
lesions within the extent of the colitis. There were 5 adenocarcinomas detected of which 
1 had prior high grade dysplasia detected only by random colonoscopic biopsies. Eight 
patients had low grade dysplastic lesions (not visible endoscopically) detected only on 
random colonoscopic biopsies, none of which had progressed till the end of follow up. 
The crude incidence rate of developing colon cancer in patients with UC was 2.45 (95% 
CI 1.06-4.83) per 1000 PYD and in those with UC and polypoid adenomas within the 
extent of inflammation was 11.07 (95% CI 3.59-25.83) per 1000 PYD.  
Figure 2 shows the Kaplan Meir curve of the cumulative risk of developing CRC 
comparing patients with a polypoid dysplastic lesion within the extent of inflammation to 
those without (log rank test p=0.007). Table 3 shows the Cox proportional hazards 
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analysis of the factors associated with the development of CRC. Presence of a polypoid 
dysplastic lesion within the extent of colitis was associated with 4 fold risk in the risk if 
subsequent CRC and this risk was maintained even after multivariate analysis adjusting 
for extent, age of diagnosis and gender.  
Discussion 
Patients with ulcerative colitis with an endoscopically resectable dysplastic polypoid 
lesions within the extent of colonic inflammation, , have nearly a 4 fold risk of 
subsequently developing cancer compared to a cohort of UC patients not having similar 
polypoid dysplastic lesions.  While 5 patients (17%) subsequently developed a 
carcinoma, of the remaining 24 patients, 10 (42%) had a recurrent polypoid dysplastic 
lesions detected on follow up which is similar to the findings of Odze et al[13]. We 
believe that taking the total duration of disease and not just the follow up period post 
polypectomy or excision of lesion should be taken into account when determining risk. 
We also adjusted the risk estimate for age, sex and extent of disease.  This reflects a 
more accurate perception of the risk of colorectal cancer in these patients. Our results 
are therefore similar to that by the Mayo group who found that the 5-year cumulative 
risk of subsequent colonic neoplasia after endoscopic resection in both those with 
sporadic adenomas as well as those with adenoma like masses to be 68.5% and 70.6% 
respectively[6].   A Dutch pathology database study showed that the adjusted risk of 
developing advanced neoplasia on follow up for patients with IBD and adenomas 
compared to IBD patients without adenomas was 2.8 fold higher (95% CI 1.0-8.2) which 
is also reflected in the results of the present study [11]. A systematic review which 
included 10 studies, with 376 IBD patients with resected polypoid dysplasia followed up 
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for a mean of 54 months, reported an pooled incidence for dysplasia and CRC of 65 
and 5.3 cases per 1000 patient years respectively[8].  
As with all retrospective analyses there are several limitations to our study. We have not 
been able to match for confounding factors like family history of colon cancer[14] and 
medication usage which could affect the risk[15]. A study from the Mayo clinic however 
did not find any association between 5ASA use and subsequent development of 
colorectal neoplasia after endoscopic resection [6]. The endoscopic procedures were 
performed by different endoscopists, which is a potential factor in influencing the 
completeness of resection and subsequent risk of recurrence although all were 
appropriately accredited.  Additionally it was no always possible to determine 
completeness of excision based on retrospective evaluation of endoscopy reports as 
this was not always explicitly commented on in reports. Diathermy artefacts could also 
preclude the histopathologists from commenting on completeness of excision especially 
when small polyps were resected with a hot biopsy forceps (as was the practice at the 
time of the study) or when larger polyps were resected piecemeal. However all 
procedures were performed by accredited endoscopists and reflects real world practice 
in a standard National Health Service setting. 
Another source of bias could have arisen because we interpreted the histology on the 
basis of the prior routine histology report and discussion of the histology at a multi-
disciplinary meeting. Due to limited storage capacity, slides over 10 years old are 
discarded by our histopathology department precluding retrospective re-examination. 
Since all the original sections could not be reviewed, the prior routine reports were used 
throughout. We believe that this is an entirely reasonable approach as the clinical 
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treatment of these patients was based on the original reports and reflects routine clinical 
practice. Various methods have been described using endoscopic and histopathological 
techniques including immunohistochemistry to characterize these lesions as sporadic 
adenomas and adenoma like masses with no current consensus on the reliability of 
these various criteria. We have avoided re-categorizing these lesions retrospectively, 
mainly because we feel that from a clinical perspective these lesions form part of the 
same spectrum, analogous to that seen in sporadic adenomas.  Lesions which are non-
resectable are likely to be bigger and harbor cancer, while endoscopically resectable 
lesions are likely to be smaller and benign[16]. None of our patients had cancer noted in 
the initial endoscopic resection specimen.  Additionally a study from the Mayo clinic 
showed that the risk of subsequent neoplasia after endoscopic reaction was similar in 
UC patients classed as having sporadic adenomas as well as those with adenoma like 
masses[6].  
The median number of biopsy specimens in this study was 8, which is very similar to 
practice elsewhere in the UK. Self-reported number of biopsies in a survey of UK 
gastroenterologist revealed that 57% take fewer than 10 biopsies per patient[17]. The St 
Mark’s group also reported a median number of 8 biopsies in their surveillance 
programme[16]. Our figures are therefore representative of UK clinical practice and can 
be generalizable to most clinical practices. This  could have led to lower identification of 
dysplasia but conversely many studies have shown an extremely low yield of dysplasia 
from non-targeted biopsies compared to targeted biopsies suggesting that the 
incremental benefit from multiple non targeted biopsies is small[7,18]. As this study was 
a single center retrospective study which depended on patient follow up in a single 
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institution and while all patients underwent colonoscopy with biopsies, this was not done 
in a protocolized fashion as evidenced by the low median number of random biopsies 
taken. These factors however are likely to bias the study towards under detection of the 
outcomes of interest.  
Polypectomy has been suggested to be adequate therapy for UC patients with 
adenomatous polyps which endoscopically or histologically resemble sporadic 
adenomas. This study demonstrates that there is an increased risk of developing 
colorectal cancer in this patient group with dysplastic polyps within the extent of 
inflammation compared to the rest of the general UC population. Patients and 
physicians need to be aware of this increased risk before deciding on treatment options. 
Complete endoscopic removal and subsequent strict endoscopic surveillance protocols 
are therefore needed after endoscopic resection of adenomatous lesions in patients 
with ulcerative colitis. Since  this is a single center retrospective study with small 
numbers, further prospective multi-centre studies are required, taking into account risk 
factors like family history of colorectal neoplasia, presence of primary sclerosing 
cholangitis, use of thiopurine and 5-aminosalicylate drugs and duration and extent of 
UC  to validate these observations. 
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Table 1: Patient characteristics of the 301 ulcerative colitis patients with and without 
a polypoid dysplastic lesion within the extent of inflammation. 
 
 
 UC with dysplastic 
adenomatous polyp within 
extent of inflammation 
UC controls without 
adenomatous polyps 
within extent of 
inflammation 
Number 29 272 
Age at diagnosis in years 
(±SD) 
49 (17) 38(20) 
Duration of colitis in years 
(±SD) 
16(10) 12(11) 
Male (%) 18(62) 144(53) 
No. with Extensive colitis 
(%) 
17(59) 144(53) 
Number of random 
biopsies: median 
12 8 
 
 
 
Table Click here to download Table Table 1 DSS rtf.rtf 
Table 2: Characteristics of the polyps within the extent of inflammation detected in 
patients with ulcerative colitis.  
 
 
Number of patients with polyps 29 
Number with > 1 polyp (%) 10 (34) 
Polyp location: number(%) 
      Caecum 
      Right Colon 
      Transverse 
      Left Colon 
 
3 (10) 
3 (10) 
3 (10) 
20 (70) 
Polyp architecture: number(%) 
     tubular 
     tubulovillous 
     villous 
 
23 (79) 
05 (17) 
1 (4) 
Size in mm : median(range) 10 (5-35) 
Grade of dysplasia: number (%) 
     Low grade dysplasia 
     Focal high grade dysplasia 
     High grade dysplasia 
 
22 (76) 
2 (7) 
5 (17) 
 
 
Table Click here to download Table Table 2 DSS rtf.rtf 
 Table 3: Cox Proportional Hazard Analysis of the Association Between the Presence of 
a polypoid dysplastic  lesions and the development of subsequent colorectal cancer.  
 
 
Factor Unadjusted HR 
(95% CI) 
Adjusted HR (95% CI) 
Dysplastic polyp within extent of 
inflammation 
4.1 (1.3-12.7) 4.0 (1.3-12.4) 
Age  (>40 year vs <40 years) 2.3 (0.3-17.7) 1.6 (0.2-13.3) 
Gender (male vsfemale) 1.4 (0.5-4.4) 1.3 (0.40-3.3) 
Disease extent (extensive vs rest) 3.2 (0.7-14.7) 3.2 (0.7-14.6) 
 
 
 
Table Click here to download Table Table 3 DSS rtf.rtf 
 
 
 
 
 
 
 
Figure Legend: 
 
Figure 1: Flow chart showing the final outcomes of patients included in this study at the 
end of follow up. 
Figure Legends
  
Figure Legend: 
 
 
Figure 2: Kaplan-Meier curve comparing the development of CRC between UC patients 
with polypoid dysplastic lesions within the extent of inflammation and the reference UC 
population. 
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